2024
Trends in Medicare Reimbursement and Service Volume of Vitreoretinal Procedures: 2000 to 2021
Li E, Adelman R. Trends in Medicare Reimbursement and Service Volume of Vitreoretinal Procedures: 2000 to 2021. Journal Of VitreoRetinal Diseases 2024, 9: 31-36. PMID: 39539838, PMCID: PMC11556364, DOI: 10.1177/24741264241292743.Peer-Reviewed Original ResearchVitreoretinal proceduresStatistically significant decreasePanretinal photocoagulation treatmentInflation-adjusted Medicare reimbursementSignificant decreaseSpearman correlationMedicare Part B National Summary Data FilesScleral bucklingEvaluate time trendsIntravitreal injectionPhotocoagulation treatmentNational reimbursement ratesSpearman correlation coefficientPractice patternsPatient coverageMedicare Physician Fee ScheduleStatistical significancePhysician fee scheduleMedicare reimbursementSignificant declineReimbursement ratesInjectionReimbursement trendsTime trendsIntravitrealCardiovascular and Cerebrovascular Adverse Events Associated with Intravitreal Anti-VEGF Monoclonal Antibodies A World Health Organization Pharmacovigilance Study
Yang J, Jung S, Kim M, Lee S, Yon D, Shin J, Lee J. Cardiovascular and Cerebrovascular Adverse Events Associated with Intravitreal Anti-VEGF Monoclonal Antibodies A World Health Organization Pharmacovigilance Study. Ophthalmology 2024, 132: 62-78. PMID: 39004231, DOI: 10.1016/j.ophtha.2024.07.008.Peer-Reviewed Original ResearchMeSH KeywordsAdverse Drug Reaction Reporting SystemsAgedAngiogenesis InhibitorsAntibodies, Monoclonal, HumanizedBevacizumabCardiovascular DiseasesCerebrovascular DisordersDatabases, FactualFemaleHumansIntravitreal InjectionsMaleMiddle AgedOdds RatioPharmacovigilanceRanibizumabReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsVascular Endothelial Growth Factor AWorld Health OrganizationConceptsIntravitreal anti-VEGF treatmentAdverse drug reactionsAnti-VEGF treatmentAnti-VEGFAtrial fibrillationIntravitreal anti-VEGF therapyCerebral hemorrhageIndividual case safety reportsInter-drugReports of myocardial infarctionMyocardial infarctionDisproportionate Bayesian reportingIntravitreal anti-VEGFAnti-VEGF therapyCarotid artery stenosisIncreasing reportsHypertensive crisisCase-noncase studySupraventricular tachycardiaAtrial flutterSubarachnoid hemorrhageIntravitrealArtery stenosisAngina pectorisOdds ratio
2018
Cluster endophthalmitis due to Stenotrophomonas maltophilia following intravitreal bevacizumab: outcomes of patients from North India
Agarwal A, Aggarwal K, Samanta R, Angrup A, Biswal M, Ray P, Dogra M, Katoch D, Bansal R, Singh R, Dogra M, Gupta V. Cluster endophthalmitis due to Stenotrophomonas maltophilia following intravitreal bevacizumab: outcomes of patients from North India. British Journal Of Ophthalmology 2018, 103: 1278. PMID: 30420442, DOI: 10.1136/bjophthalmol-2018-313131.Peer-Reviewed Original ResearchConceptsPrimary pars plana vitrectomyIntraocular pressureIntravitreal bevacizumabCluster endophthalmitisPainful diminution of visionPars plana vitrectomyRaised intraocular pressureDiminution of visionContaminated hospital surfacesOutcomes of patientsGram-negative bacilliSeverity of inflammationManagement of patientsIntravitreal antibioticsSevere vitritisPlana vitrectomyCorneal edemaIntravitreal injectionMedia clarityBCVANorth IndiaRetrospective studyClinical featuresIntravitrealPersistent inflammationUtility of MALDI-TOF mass spectrometry in an outbreak investigation of acute endophthalmitis following intravitreal injection
Angrup A, Krishnamoorthi S, Biswal M, Gautam V, Ray P, Agarwal A, Dogra M, Singh R, Katoch D, Gupta V. Utility of MALDI-TOF mass spectrometry in an outbreak investigation of acute endophthalmitis following intravitreal injection. Journal Of Hospital Infection 2018, 100: e253-e256. PMID: 29605188, DOI: 10.1016/j.jhin.2018.03.032.Peer-Reviewed Original ResearchConceptsIntravitreal injectionMatrix-Assisted Laser Desorption/Ionization Mass SpectrometryLaser desorption/ionization mass spectrometryMass spectrometryIntravitreal injection of bevacizumabDesorption/ionization mass spectrometryTreating choroidal neovascularizationInjection of bevacizumabRecombinant humanized monoclonal antibodyInhibit tumor angiogenesisMALDI-TOF mass spectrometryHuman monoclonal antibodyOff-label useAcute endophthalmitisEndophthalmitis outbreakChoroidal neovascularizationMultiple dosesTumor angiogenesisBevacizumabEarly diagnosisMonoclonal antibodiesStenotrophomonas maltophiliaEndophthalmitisIntravitrealOutbreak investigationManagement of multi drug resistant endogenous Klebsiella pneumoniae endophthalmitis with intravitreal and systemic colistin
Dogra M, Sharma M, Katoch D, Dogra M. Management of multi drug resistant endogenous Klebsiella pneumoniae endophthalmitis with intravitreal and systemic colistin. Indian Journal Of Ophthalmology 2018, 66: 596-597. PMID: 29582834, PMCID: PMC5892076, DOI: 10.4103/ijo.ijo_809_17.Peer-Reviewed Original ResearchConceptsEndogenous Klebsiella pneumoniae endophthalmitisComplete resolution of infectionBilateral endogenous endophthalmitisResolution of infectionGrowth of Klebsiella pneumoniaeEndogenous endophthalmitisIntravenous colistinSystemic colistinVitreous tapVisual acuityLeft eyeSurgical drainageComplete resolutionPancreatic pseudocystFollow-upColistinDrain fluidTested antibioticsEndophthalmitisPseudocystBacterial cultureEyesIntravitrealAcuityPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply